Systemic Inflammatory Response Syndrome and Outcomes in Ischemic Patients Treated with Endovascular Treatment

References

• Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826–837. doi:10.1038/nri287321088683
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhu T, Li H, et al. Plasma interleukin-37 is elevated in acute ischemic stroke patients and probably associated with 3-month functional prognosis. Clin Interv Aging. 2020;15:1285–1294. doi:10.2147/CIA.S23018632801675
   PubMed Web of Science ®Google Scholar
• Dénes A, Ferenczi S, Kovács KJ. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation. 2011;8:164. doi:10.1186/1742-2094-8-16422114895
   PubMed Web of Science ®Google Scholar
• Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15(8):946–950. doi:10.1038/nm.199919648929
   PubMed Web of Science ®Google Scholar
• Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058–1066. doi:10.1016/S1474-4422(19)30078-X31296369
   PubMed Web of Science ®Google Scholar
• Audebert HJ, Rott MM, Eck T, Haberl RL. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke. 2004;35(9):2128–2133. doi:10.1161/01.STR.0000137607.61697.7715272127
   PubMed Web of Science ®Google Scholar
• Boehme AK, Kapoor N, Albright Karen C, et al. Systemic inflammatory response syndrome in tissue-type plasminogen activator–treated patients is associated with worse short-term functional outcome. Stroke. 2013;44(8):2321–2323. doi:10.1161/STROKEAHA.113.00137123704110
   PubMed Web of Science ®Google Scholar
• Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab. 2012;32(9):1677–1698. doi:10.1038/jcbfm.2012.8822739623
   PubMed Web of Science ®Google Scholar
• Perez-de-Puig I, Miró-Mur F, Ferrer-Ferrer M, et al. Neutrophil recruitment to the brain in mouse and human ischemic stroke. Acta Neuropathol. 2015;129(2):239–257. doi:10.1007/s00401-014-1381-025548073
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50(12):e344–e418.31662037
   PubMed Web of Science ®Google Scholar
• Rabinstein AA, Albers GW, Brinjikji W, Koch S. Factors that may contribute to poor outcome despite good reperfusion after acute endovascular stroke therapy. Int J Stroke. 2019;14(1):23–31. doi:10.1177/174749301879997930188259
   PubMed Web of Science ®Google Scholar
• Boisseau W, Desilles JP, Fahed R, et al. Neutrophil count predicts poor outcome despite recanalization after endovascular therapy. Neurology. 2019;93(5):e467–e475. doi:10.1212/WNL.000000000000785931239356
   PubMed Web of Science ®Google Scholar
• Diprose WK, Liem B, Wang MTM, et al. Impact of body temperature before and after endovascular thrombectomy for large vessel occlusion stroke. Stroke. 2020;51(4):1218–1225.32102631
   PubMed Web of Science ®Google Scholar
• Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.STR.24.1.357678184
   PubMed Web of Science ®Google Scholar
• Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol. 2005;26(7):1789–1797.16091531
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest. 1992;101(6):1644–1655. doi:10.1378/chest.101.6.16441303622
   PubMed Web of Science ®Google Scholar
• Zha A, Vahidy F, Randhawa J, et al. Association between splenic contraction and the systemic inflammatory response after acute ischemic stroke varies with age and race. Transl Stroke Res. 2018;9(5):484–492. doi:10.1007/s12975-017-0596-529282627
   PubMed Web of Science ®Google Scholar
• Neumann J, Riek-Burchardt M, Herz J, et al. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol. 2015;129(2):259–277. doi:10.1007/s00401-014-1355-225391494
   PubMed Web of Science ®Google Scholar
• Kollikowski AM, Schuhmann MK, Nieswandt B, Müllges W, Stoll G, Pham M. Local leukocyte invasion during hyperacute human ischemic stroke. Ann Neurol. 2020;87(3):466–479. doi:10.1002/ana.2566531899551
   PubMed Web of Science ®Google Scholar
• Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke. 2001;32(9):1989–1993. doi:10.1161/hs0901.09564611546886
   PubMed Web of Science ®Google Scholar
• Desilles JP, Syvannarath V, Ollivier V, et al. Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation. Stroke. 2017;48(7):1932–1940. doi:10.1161/STROKEAHA.117.01708028526762
   PubMed Web of Science ®Google Scholar
• Semerano A, Laredo C, Zhao Y, et al. Leukocytes, collateral circulation, and reperfusion in ischemic stroke patients treated with mechanical thrombectomy. Stroke. 2019;50(12):3456–3464.31619153
   PubMed Web of Science ®Google Scholar
• Liebeskind DS, Cotsonis GA, Saver JL, et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011;69(6):963–974. doi:10.1002/ana.2235421437932
   PubMed Web of Science ®Google Scholar
• García-Culebras A, Durán-Laforet V, Peña-Martínez C, et al. Role of TLR4 (toll-like receptor 4) in N1/N2 neutrophil programming after stroke. Stroke. 2019;50(10):2922–2932.31451099
   PubMed Web of Science ®Google Scholar
• Liesz A, Dalpke A, Mracsko E, et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci. 2015;35(2):583–598. doi:10.1523/JNEUROSCI.2439-14.201525589753
   PubMed Web of Science ®Google Scholar
• la Sala A, Pontecorvo L, Agresta A, Rosano G, Stabile E. Regulation of collateral blood vessel development by the innate and adaptive immune system. Trends Mol Med. 2012;18(8):494–501. doi:10.1016/j.molmed.2012.06.00722818027
   PubMed Web of Science ®Google Scholar
• Chu HX, Kim HA, Lee S, et al. Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Met. 2013;34:450–459. doi:10.1038/jcbfm.2013.217
   Web of Science ®Google Scholar
• Holger K, Eltzschig TE. Ischemia and reperfusion—from mechanism to translation. Nat Med. 2011;17(11):1391–1401. doi:10.1038/nm.250722064429
   PubMed Web of Science ®Google Scholar
• Elkins J, Veltkamp R, Montaner J, et al. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2017;16(3):217–226.28229893
   PubMed Web of Science ®Google Scholar